Suvretta Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-280,760	Closed	-$2.21M	–	93
2023 Q3	$2.21M	Hold	280,760	–	–	0.12%	61
2023 Q2	$2.8M	Buy	+280,760	New	+$2.8M	0.15%	67